Leleu, X
Kyriakou, C
Vande Broek, I
Murphy, P
Bacon, P
Lewis, P
Gilet, H
Arnould, B
Petrucci, M T
Article History
Received: 18 August 2016
Revised: 16 January 2017
Accepted: 31 January 2017
First Online: 17 March 2017
Competing interests
: PM, XL, CK, IVB and MTP were Consultant/Advisor for Celgene and received honoraria from Celgene. XL also received honoraria and travel support from Janssen, Takeda, BMS, Novartis, Amgen, Leopharma and Sanofi. PB and PL declare employment and equity ownership in Celgene. During the course of study and manuscript development, PL was an employee of Celgene. HG, former employee of Mapi, and BA, employee of Mapi, were Consultant/Advisor for Celgene and received research funding from Celgene.